Stuart Essig is chairman of Integra LifeSciences Holdings Corporation (NASDAQ: IART). He served as the company’s chief executive officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 18-year tenure with the company, Integra has grown revenues from $15 million to almost $1 billion and its market capitalization from approximately $100 million to a levered valuation of more than $3.5 billion. Stuart also serves as managing partner of Prettybrook Partners, LLP. He is chairman of Breg, Inc., and director of St. Jude Medical, Inc. (NYSE: STJ), SeaSpine, Inc. (NASDAQ:SPNE) and Owens & Minor, Inc. (NYSE: OMI). Previously, Stuart served on the boards of Zimmer Holdings, Inc. (NYSE: ZMH) and Vital Signs, Inc. (NASDAQ:VITL). Prior to Integra, Stuart was a managing director in mergers and acquisitions for the Goldman Sachs Group, Inc., specializing in the medical device, pharmaceutical and biotechnology sectors. After earning his undergraduate degree from Princeton University, Stuart earned a master’s in business administration and doctorate in financial economics from the University of Chicago.